Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study

Despite some variability in ideal serum Adalimumab (ADA) concentrations, there is increasing evidence that higher concentrations of anti-TNF-α agents can be associated with sustained efficacy, and low or undetectable levels may lead to loss of response. This study aims to correlate serum ADA concent...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Letícia Rodrigues, Magro, Daniela Oliveira, Teixeira, Fábio Vieira, Parra, Rogério Serafim, Miranda, Eron Fábio, Féres, Omar, Saad-Hossne, Rogério, Soares Prates Herrerias, Giedre, Nisihara, Renato Mitsunori, Coy, Claudio Saddy Rodrigues, Sassaki, Ligia Yukie, Kotze, Paulo Gustavo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967155/
https://www.ncbi.nlm.nih.gov/pubmed/36839908
http://dx.doi.org/10.3390/pharmaceutics15020586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967155/
https://www.ncbi.nlm.nih.gov/pubmed/36839908
http://dx.doi.org/10.3390/pharmaceutics15020586

Ejemplares similares